TI
HRMY icon

Tidal Investments’s Harmony Biosciences HRMY Stock Holding History

Tidal Investments’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Sell
8,972
-4,776
-35% -$151K ﹤0.01% 2268
2026
Q1 		$385K Buy
+13,748
New +$451K ﹤0.01% 1940

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tidal Investments's HRMY Position: Q2 2026 in Review

Tidal Investments reduced its Harmony Biosciences (HRMY) stake by 35% in Q2 2026, selling an estimated $151K and leaving 8,972 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #2268.

Tidal Investments first reported a position in HRMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $385K in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Tidal Investments held 8,972 shares of Harmony Biosciences worth $327K as of Q2 2026.
  • Tidal Investments sold 4,776 Harmony Biosciences shares in Q2 2026, an estimated $151K.
  • Harmony Biosciences made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #2268 holding.
  • Tidal Investments first reported a position in Harmony Biosciences in Q1 2026 and has held it in 2 quarters since.
  • Tidal Investments's Harmony Biosciences position peaked at $385K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.